Cargando…

Loss of 5-Hydroxymethylcytosine as an Epigenetic Signature That Correlates With Poor Outcomes in Patients With Medulloblastoma

Medulloblastoma, as the most common malignant brain tumor in children, exhibits highly dysregulated DNA methylation. The novel epigenetic marker—5-hydroxymethylcytosine (5hmC) plays essential role in gene regulation during brain development and in brain tumors. However, the biological and clinical i...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhao, Fu, Zhang, Zhi-Wei, Zhang, Jing, Zhang, Shun, Zhang, Heng, Zhao, Chi, Chen, Yang, Luo, Lin, Tong, Wei-Min, Li, Chunde, Niu, Yamei, Liu, Pinan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2021
Materias:	Oncology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7945595/ https://www.ncbi.nlm.nih.gov/pubmed/33718152 http://dx.doi.org/10.3389/fonc.2021.603686

Ejemplares similares

Characterization of global 5-hydroxymethylcytosine in pediatric posterior fossa ependymoma
por: Wu, Tao, et al.
Publicado: (2020)

TOP2A correlates with poor prognosis and affects radioresistance of medulloblastoma
por: Zhang, Yufeng, et al.
Publicado: (2022)

5-hydroxymethylcytosine loss is associated with poor prognosis for patients with WHO grade II diffuse astrocytomas
por: Zhang, Feng, et al.
Publicado: (2016)

Integrated 5-hydroxymethylcytosine and fragmentation signatures as enhanced biomarkers in lung cancer
por: Hu, Xinlei, et al.
Publicado: (2022)

The Impact of the HydroxyMethylCytosine epigenetic signature on DNA structure and function
por: Battistini, Federica, et al.
Publicado: (2021)

MEDB-23. Targeting epigenetic dysregulation in medulloblastoma with poor prognosis
por: Badodi, Sara, et al.
Publicado: (2022)

The clinical treatment and outcome of cerebellopontine angle medulloblastoma: a retrospective study of 15 cases
por: Wu, Tao, et al.
Publicado: (2020)

5-Hydroxymethylcytosine signatures in circulating cell-free DNA as diagnostic biomarkers for human cancers
por: Li, Wenshuai, et al.
Publicado: (2017)

LC–MS-Based Urine Metabolomics Analysis for the Diagnosis and Monitoring of Medulloblastoma
por: Liu, Xiaoyan, et al.
Publicado: (2022)

5-Hydroxymethylcytosine Loss in Conjunctival Melanoma
por: Stahl, Alexandre, et al.
Publicado: (2021)

5-Hydroxymethylcytosine: a new kid on the epigenetic block?
por: Matarese, Filomena, et al.
Publicado: (2011)

Epigenetic Optical Mapping of 5-Hydroxymethylcytosine in Nanochannel Arrays
por: Gabrieli, Tslil, et al.
Publicado: (2018)

Environmental Epigenetics and Genome Flexibility: Focus on 5-Hydroxymethylcytosine
por: Efimova, Olga A., et al.
Publicado: (2020)

5-Hydroxymethylcytosine as a potential epigenetic biomarker in papillary thyroid carcinoma
por: Tong, Mengying, et al.
Publicado: (2019)

Congenital medulloblastoma in two brothers with SUFU-mutated Gorlin-Goltz syndrome: Case reports and literature review
por: Chen, Yufan, et al.
Publicado: (2022)

Changes in DNA 5-Hydroxymethylcytosine Levels and the Underlying Mechanism in Non-functioning Pituitary Adenomas
por: Xu, Yiwen, et al.
Publicado: (2020)

Loss of 5-hydroxymethylcytosine expression is near-universal in B-cell lymphomas with variable mutations in epigenetic regulators
por: Tanager, Kevin S., et al.
Publicado: (2021)

5-hydroxymethylcytosine represses the activity of enhancers in embryonic stem cells: a new epigenetic signature for gene regulation
por: Choi, Inchan, et al.
Publicado: (2014)

Tumor-Associated Macrophages Correlate With Prognosis in Medulloblastoma
por: Zhang, Jin, et al.
Publicado: (2022)

A Metastasis-Related lncRNA Signature Correlates With the Prognosis in Clear Cell Renal Cell Carcinoma
por: Dou, Qian, et al.
Publicado: (2021)

Medulloblastoma and the DNA Damage Response
por: McSwain, Leon F., et al.
Publicado: (2022)

Loss of the epigenetic mark, 5-Hydroxymethylcytosine, correlates with small cell/nevoid subpopulations and assists in microstaging of human melanoma
por: Lee, Jonathan J., et al.
Publicado: (2015)

5-hydroxymethylcytosines regulate gene expression as a passive DNA demethylation resisting epigenetic mark in proliferative somatic cells
por: Wei, Alex, et al.
Publicado: (2023)

5-Hydroxymethylcytosine signatures in cell-free DNA provide information about tumor types and stages
por: Song, Chun-Xiao, et al.
Publicado: (2017)

5-Methylcytosine and 5-Hydroxymethylcytosine Signatures Underlying Pediatric Cancers
por: Jhanwar, Shalu, et al.
Publicado: (2019)

Genome-wide 5-hydroxymethylcytosine modification pattern is a novel epigenetic feature of globozoospermia
por: Wang, Xiu-Xia, et al.
Publicado: (2015)

Synthesis of novel derivatives of 5-hydroxymethylcytosine and 5-formylcytosine as tools for epigenetics
por: Chentsova, Anna, et al.
Publicado: (2014)

Epigenetic mechanisms involved in the effects of stress exposure: focus on 5-hydroxymethylcytosine
por: Hack, Laura M., et al.
Publicado: (2016)

Loss of 5-hydroxymethylcytosine as a Poor Prognostic Factor for Primary Testicular Diffuse Large B-cell Lymphoma
por: Shen, Ye, et al.
Publicado: (2022)

Whole-genome sequencing of extrachromosomal circular DNA of cerebrospinal fluid of medulloblastoma
por: Zhu, Yi, et al.
Publicado: (2022)

Prognostic signature construction of energy metabolism-related genes in pancreatic cancer
por: Liu, Hao, et al.
Publicado: (2022)

Tissue-specific 5-hydroxymethylcytosine landscape of the human genome
por: He, Bo, et al.
Publicado: (2021)

Epigenetic Drivers in Pediatric Medulloblastoma
por: Roussel, Martine F., et al.
Publicado: (2017)

The advent of precision epigenetics for medulloblastoma
por: Li, Chaoxi, et al.
Publicado: (2020)

Epigenetics and immune cells in medulloblastoma
por: Gorini, Francesca, et al.
Publicado: (2023)

Epigenetic reprogramming in pancreatic premalignancy and clinical implications
por: Zhang, Wei, et al.
Publicado: (2023)

Radiomic Features From Multi-Parameter MRI Combined With Clinical Parameters Predict Molecular Subgroups in Patients With Medulloblastoma
por: Yan, Jing, et al.
Publicado: (2020)

Cerebellar Liponeurocytoma Mimicking Medulloblastoma: Case Report of a Childhood and Literature Review
por: Dong, Changhui, et al.
Publicado: (2021)

Loss of IL-34 Expression Indicates Poor Prognosis in Patients With Lung Adenocarcinoma
por: Wang, Zhendong, et al.
Publicado: (2021)

5′-methylcytosine and 5′-hydroxymethylcytosine Each Provide Epigenetic Information to the Mouse Zygote
por: Li, Yan, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_u60ams5e748ggab47n6hc8pska